MUTYH
Universal Cellular Machinery · DNA Damage Repair & Genomic Integrity
Why does it matter whether a MUTYH finding affects one or both gene copies?
MUTYH makes an enzyme used in repairing particular DNA-base errors. The inheritance pattern and number of pathogenic copies are central to interpreting associated polyposis risk, so an unspecified variant label is insufficient.
- Common Gene Name
- mutY DNA glycosylase
- NCBI Gene ID
- 4595
- Chromosome
- 1
Clinical Evidence Status
Actionability report availableEstablished disease relationship
These labels describe available evidence about a gene. They do not classify your variant or recommend a treatment.
Answer Sources
Explore supporting evidence (8 records)
| Condition or drug | Evidence | Grade / status | Context | Source |
|---|---|---|---|---|
| familial ovarian cancer | ClinGen gene-disease validity | Disputed | Autosomal recessive | View source 2023-12-20 |
| familial ovarian cancer | ClinGen gene-disease validity | Disputed | Autosomal dominant | View source 2023-12-20 |
| familial adenomatous polyposis 2 | ClinGen gene-disease validity | Definitive | Autosomal recessive | View source 2022-06-20 |
| hereditary breast carcinoma | ClinGen gene-disease validity | Disputed | Autosomal recessive | View source 2023-12-21 |
| colorectal cancer | ClinGen gene-disease validity | Disputed | Autosomal dominant | View source 2023-03-24 |
| hereditary breast carcinoma | ClinGen gene-disease validity | Refuted | Autosomal dominant | View source 2023-12-21 |
| MUTYH-associated polyposis | MedlinePlus related condition | Association type varies; no grade assigned here | View source 2025-08 | |
| MUTYH-Associated Polyposis | ClinGen clinical actionability | Scored report; not a validity grade | Adult | View source 2022-02-09 |
Source snapshot: 2026-09-09. Consumer text updated: 2026-09-10. Source dates describe the cited records, not a new clinical review.
← Back to Universal Cellular Machinery